These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 20415602)

  • 41. RNA interference and potential therapeutic applications of short interfering RNAs.
    Karagiannis TC; El-Osta A
    Cancer Gene Ther; 2005 Oct; 12(10):787-95. PubMed ID: 15891770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNA interference: new mechanisms for targeted treatment?
    Woessmann W; Damm-Welk C; Fuchs U; Borkhardt A
    Rev Clin Exp Hematol; 2003 Sep; 7(3):270-91. PubMed ID: 15024970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNA interference therapy via functionalized scaffolds.
    Monaghan M; Pandit A
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):197-208. PubMed ID: 21241760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RNA interference (RNAi) in hematology.
    Scherr M; Steinmann D; Eder M
    Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic delivery of therapeutics to neuronal tissues: a barrier modulation approach.
    Campbell M; Ozaki E; Humphries P
    Expert Opin Drug Deliv; 2010 Jul; 7(7):859-69. PubMed ID: 20486860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular advances of brain tumors in radiation oncology.
    Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
    Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug research. Roche exits RNAi field, cuts 4800 jobs.
    Couzin-Frankel J
    Science; 2010 Nov; 330(6008):1163. PubMed ID: 21109638
    [No Abstract]   [Full Text] [Related]  

  • 50. Potential clinical applications of siRNA technique: benefits and limitations.
    Chen SH; Zhaori G
    Eur J Clin Invest; 2011 Feb; 41(2):221-32. PubMed ID: 20964680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of the current status of siRNA nanomedicines in the treatment of cancer.
    Resnier P; Montier T; Mathieu V; Benoit JP; Passirani C
    Biomaterials; 2013 Sep; 34(27):6429-43. PubMed ID: 23727262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delivery of RNAi therapeutics: work in progress.
    Miller AD
    Expert Rev Med Devices; 2013 Nov; 10(6):781-811. PubMed ID: 24195461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RNAi based approaches to the treatment of malignant glioma.
    Mathupala SP; Guthikonda M; Sloan AE
    Technol Cancer Res Treat; 2006 Jun; 5(3):261-9. PubMed ID: 16700622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene and viral therapy for glioblastoma: a review of clinical trials and future directions.
    Mohyeldin A; Chiocca EA
    Cancer J; 2012; 18(1):82-8. PubMed ID: 22290261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety profile of RNAi nanomedicines.
    Barros SA; Gollob JA
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1730-7. PubMed ID: 22732527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using large-scale RNAi screens to identify novel drug targets for cancer.
    Nijwening JH; Beijersbergen RL
    IDrugs; 2010 Nov; 13(11):772-7. PubMed ID: 21046524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNAi-based nanomedicines for targeted personalized therapy.
    Daka A; Peer D
    Adv Drug Deliv Rev; 2012 Oct; 64(13):1508-21. PubMed ID: 22975009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.
    Quant EC; Wen PY
    Neuroimaging Clin N Am; 2010 Aug; 20(3):425-48. PubMed ID: 20708556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RNA interference advances to early-stage clinical trials.
    Brower V
    J Natl Cancer Inst; 2010 Oct; 102(19):1459-61. PubMed ID: 20870977
    [No Abstract]   [Full Text] [Related]  

  • 60. Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches.
    Gilbert MR
    Semin Oncol; 2011 Dec; 38 Suppl 4():S21-33. PubMed ID: 22078645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.